Broad Genomic Sequencing Improves Survival in First-Line Setting in Advanced NSCLC

Broad-based genomic sequencing linked to improved progression-free and overall survival in first-line, but not second-line, setting
Human lung cancer with dna strand. 3d illustration
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on: 
Updated on: 
Loading content, please wait...